Toward reducing risks and costs of egg donation: a preliminary report.
To use clomiphene citrate for ovarian stimulation of egg donors as a means of reducing the risk, discomfort, and inconvenience for egg donors and reducing costs for recipients. Prospective nonrandomized clinical study. Private reproductive center. Egg donation recipients and their anonymous donors. Clomiphene citrate was administered to egg donors rather than a GnRH agonist and gonadotropins before oocyte retrieval. Pregnancy. Eleven oocyte retrievals were performed and conception occurred in four cycles, three of which delivered. Clomiphene citrate appears to be a reasonable less expensive method of ovarian stimulation for egg donation in normospermic males and appears more acceptable to potential donors.